306 related articles for article (PubMed ID: 25325988)
21. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
Das S; Amin SA; Jha T
Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437
[TBL] [Abstract][Full Text] [Related]
22. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
Lively TJ; Bosco DB; Khamis ZI; Sang QX
Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.
Shi Y; Ma X; Fang G; Tian X; Ge C
NanoImpact; 2021 Jan; 21():100293. PubMed ID: 35559782
[TBL] [Abstract][Full Text] [Related]
25. Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Shiraga M; Yano S; Yamamoto A; Ogawa H; Goto H; Miki T; Miki K; Zhang H; Sone S
Cancer Res; 2002 Oct; 62(20):5967-73. PubMed ID: 12384564
[TBL] [Abstract][Full Text] [Related]
26. Matrix Metalloproteinases: A challenging paradigm of cancer management.
Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
[TBL] [Abstract][Full Text] [Related]
27. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
28. Imaging matrix metalloproteinase expression in tumors.
Li WP; Anderson CJ
Q J Nucl Med; 2003 Sep; 47(3):201-8. PubMed ID: 12897711
[TBL] [Abstract][Full Text] [Related]
29. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
30. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
Rashid ZA; Bardaweel SK
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
[TBL] [Abstract][Full Text] [Related]
31. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
[TBL] [Abstract][Full Text] [Related]
32. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
33. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
Overall CM; Kleifeld O
Nat Rev Cancer; 2006 Mar; 6(3):227-39. PubMed ID: 16498445
[TBL] [Abstract][Full Text] [Related]
34. Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Mitsiades N; Poulaki V; Mitsiades CS; Anderson KC
Expert Opin Investig Drugs; 2001 Jun; 10(6):1075-84. PubMed ID: 11772236
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.
Kuhad A; Singh P; Chopra K
Expert Opin Ther Targets; 2015 Feb; 19(2):177-85. PubMed ID: 25243524
[TBL] [Abstract][Full Text] [Related]
37. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
Jodele S; Blavier L; Yoon JM; DeClerck YA
Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
[TBL] [Abstract][Full Text] [Related]
38. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
[TBL] [Abstract][Full Text] [Related]
39. [Role of metalloproteinases and their inhibitors in tumors].
Coronato S; Laguens G; Di Girolamo V
Medicina (B Aires); 2012; 72(6):495-502. PubMed ID: 23241294
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
